AG真人官方

STOCK TITAN

VSee Health Appeals NASDAQ Staff Delisting Notice

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags

VSee Health (NASDAQ:VSEE) announced it is appealing a NASDAQ Staff Determination to delist its common stock from the Nasdaq Capital Market. The delisting notice was received on August 5th, 2025, citing non-compliance with filing requirements for the 2024 Annual Report and Q1 2025 Quarterly Report.

The company has requested a hearing before the Nasdaq Listing Qualifications Panel, which automatically stays the delisting for 15 days. VSee Health plans to request an extended stay pending the hearing. If the appeal is unsuccessful, the company's stock could move to trading on the OTC Bulletin Board.

VSee Health (NASDAQ:VSEE) ha annunciato che presenter脿 ricorso contro una determinazione del personale del NASDAQ che ne dispone la cancellazione delle azioni ordinarie dal Nasdaq Capital Market. L'avviso di delisting 猫 stato ricevuto il 5 agosto 2025, indicando la mancata conformit脿 agli obblighi di deposito per il Rapporto annuale 2024 e il Rapporto trimestrale del primo trimestre 2025.

L'azienda ha chiesto un'udienza davanti al Nasdaq Listing Qualifications Panel, che sospende automaticamente il delisting per 15 giorni. VSee Health intende richiedere una proroga della sospensione in attesa dell'udienza. Se l'appello dovesse fallire, le azioni della societ脿 potrebbero essere trasferite al OTC Bulletin Board.

VSee Health (NASDAQ:VSEE) anunci贸 que apelar谩 una determinaci贸n del personal de NASDAQ para excluir sus acciones ordinarias del Nasdaq Capital Market. La notificaci贸n de delisting se recibi贸 el 5 de agosto de 2025, citando el incumplimiento de los requisitos de presentaci贸n del Informe anual 2024 y del Informe trimestral del primer trimestre de 2025.

La empresa ha solicitado una audiencia ante el Nasdaq Listing Qualifications Panel, lo que suspende autom谩ticamente el delisting durante 15 d铆as. VSee Health planea solicitar una pr贸rroga de la suspensi贸n mientras se celebra la audiencia. Si la apelaci贸n no prospera, las acciones de la compa帽铆a podr铆an pasar a cotizar en el OTC Bulletin Board.

VSee Health (NASDAQ:VSEE)電� Nasdaq Capital Market鞐愳劀 氤错喌欤茧ゼ 靸侅灔韽愳頃橂牑電� NASDAQ 歆侅洂鞚� 瓴办爼鞐� 雽頃� 頃唽頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 靸侅灔韽愳 韱奠電� 2025雲� 8鞗� 5鞚�鞐� 鞝戩垬霅橃棃鞙茧┌, 2024 鞐半氤搓碃靹�鞕赌 2025雲� 1攵勱赴 攵勱赴氤搓碃靹� 鞝滌稖 鞚橂 攵堨澊頄夓潉 鞚挫湢搿� 霌れ棃鞀惦媹雼�.

須岇偓電� Nasdaq Listing Qualifications Panel鞐� 鞁Μ毳� 鞖旍箔頄堨溂氅�, 鞚措 鞚疙暣 靸侅灔韽愳電� 鞛愲彊鞙茧 15鞚缄皠 鞙犾槇霅╇媹雼�. VSee Health電� 鞁Μ臧 鞐措Υ 霑岅箤歆 鞙犾槇 旮瓣皠 鞐办灔鞚� 鞁犾箔頃� 瓿勴殟鞛呺媹雼�. 頃唽臧 鞁ろ尐頃� 瓴届毎 須岇偓 欤检嫕鞚 OTC Bulletin Board鞐愳劀 瓯半灅霅� 靾� 鞛堨姷雼堧嫟.

VSee Health (NASDAQ:VSEE) a annonc茅 qu'elle faisait appel d'une d茅cision du personnel du NASDAQ visant 脿 radier ses actions ordinaires du Nasdaq Capital Market. L'avis de radiation a 茅t茅 re莽u le 5 ao没t 2025, invoquant le non-respect des obligations de d茅p么t pour le rapport annuel 2024 et le rapport trimestriel du 1er trimestre 2025.

La soci茅t茅 a demand茅 une audience devant le Nasdaq Listing Qualifications Panel, ce qui suspend automatiquement la radiation pendant 15 jours. VSee Health pr茅voit de demander une prolongation de cette suspension en attendant l'audience. Si l'appel 茅choue, les actions de la soci茅t茅 pourraient passer 脿 une cotation sur le OTC Bulletin Board.

VSee Health (NASDAQ:VSEE) teilte mit, dass das Unternehmen gegen eine Entscheidung der NASDAQ-Mitarbeiter zur Streichung seiner Stammaktien vom Nasdaq Capital Market Berufung einlegt. Die Delisting-Mitteilung ging am 5. August 2025 ein und nannte die Nicht-Einhaltung der Einreichungsanforderungen f眉r den Jahresbericht 2024 und den Quartalsbericht f眉r das 1. Quartal 2025 als Grund.

Das Unternehmen hat eine Anh枚rung vor dem Nasdaq Listing Qualifications Panel beantragt, wodurch das Delisting automatisch f眉r 15 Tage ausgesetzt wird. VSee Health beabsichtigt, eine Verl盲ngerung der Aussetzung bis zur Anh枚rung zu beantragen. Sollte die Berufung erfolglos bleiben, k枚nnten die Aktien des Unternehmens zum OTC Bulletin Board wechseln.

Positive
  • None.
Negative
  • Company failed to file 2024 Annual Report and Q1 2025 Quarterly Report
  • Risk of delisting from NASDAQ Capital Market
  • Potential downgrade to OTC Bulletin Board trading

SAN JOSE, CA / / August 12, 2025 / VSee Health, Inc. (Nasdaq:VSEE) (the "Company"), a leader in telehealth solutions, today announced that it has requested a hearing before a Nasdaq Listing Qualifications Panel to appeal an earlier Staff Determination to delist the Company's common stock from the Nasdaq Capital Market.

VSee Health received a letter from the Nasdaq Stock Market ("Nasdaq") on August 5th, 2025 indicating that the Company did not comply with the NASDAQ's filing requirements because it had not filed its Annual Report on Form 10-K for period ending December 31, 2024, and its Quarterly Report on Form 10-Q for the period ending March 31, 2025. Following procedures set forth in the Nasdaq rules, VSee Health has requested a hearing before a Nasdaq Listing Qualifications Panel (the "Panel") to review the Staff Determination. The appeal will automatically stay the delisting for 15 days. The Company plans to request a further stay pending the hearing, which, if approved, would allow the Company to continue to trade on the Nasdaq Capital Market. There can be no assurance however, that the Panel will grant the Company request for continued listing on the Nasdaq Capital Market or such extended stay.

In the event that the Panel denies the Company's request for continued listing on the Nasdaq Capital Market, the Company's common stock could be eligible to trade on the OTC Bulletin Board.

About VSee Health

VSee Health, Inc. (Nasdaq:VSEE) is a leading provider of telehealth solutions, specializing in real-time virtual care, clinical review, and billing services. Its technology powers healthcare networks and organizations worldwide, enabling seamless patient-provider interactions and ensuring efficient care delivery. Field-hardened on over 1.5M HIPAA-compliant video encounters every month, VSee Health's highly scalable, customizable telehealth building blocks each meet stringent security standards. VSee Health has deployed services in over 50 countries, including Iraq, Syria, Marshall Islands and El Salvador. Its clients include NASA, US Department of Health and Human Services, McKesson, Magellan, DaVita, GE, countless startups, and the entire country of Qatar. VSee Health also provides tailored solutions for critical shortage areas such as critical care and teleradiology. VSee Health is committed to empowering high quality healthcare access and reducing physician burnout and workforce shortages through its telehealth technology. For more information, please visit .

Forward-Looking Statements

Matters discussed in this news release that are not statements of historical or current facts, including but not limited to those relating to VSee Health's ability to improve healthcare access and provider efficiencies, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance or achievements to be materially different from historical results or from any future performance or achievements expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information on risk factors relating to VSee Health and its technology and billing services is included from time to time in the "Cautionary Note Regarding Forward-Looking Statements," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of VSee Health's periodic and current filings with the SEC, which are also made available on VSee Health's website at . Forward-looking statements speak only as of the date they are made, and VSee Health undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.

Contact:

VSee Health
Anne Chang
[email protected]

VSee Investor Contact:
Milton Chen
VSee Health
[email protected]

SOURCE: VSee Health, Inc.



View the original on ACCESS Newswire

FAQ

Why is VSee Health (VSEE) facing NASDAQ delisting in 2025?

VSee Health is facing delisting for failing to file its 2024 Annual Report and Q1 2025 Quarterly Report as required by NASDAQ listing requirements.

What happens to VSEE stock if the NASDAQ delisting appeal fails?

If the appeal fails, VSee Health's stock would be delisted from NASDAQ and could become eligible to trade on the OTC Bulletin Board.

When did VSee Health receive the NASDAQ delisting notice?

VSee Health received the NASDAQ delisting notice on August 5th, 2025.

How long will VSee Health's delisting be stayed during the appeal process?

The delisting is automatically stayed for 15 days, with the company planning to request an extended stay pending the hearing.

What is VSee Health doing to prevent NASDAQ delisting?

VSee Health has requested a hearing before the Nasdaq Listing Qualifications Panel to appeal the delisting determination and plans to request an extended stay.
VSee Health, Inc.

NASDAQ:VSEE

VSEE Rankings

VSEE Latest News

VSEE Stock Data

21.16M
6.52M
58.35%
4.94%
4.28%
Health Information Services
Services-health Services
United States
BOCA RATON